Creative Biolabs Inc.
Shirley, NY
- UEI
- V595TMBX2117
- CAGE
- 81Z14
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 17 Ramsey Rd Ste 203, Shirley, NY 11967, USA
- Website
- creative-biolabs.com
- Founded
- 2005
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Capital Goods
- Construction & Engineering
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $225,680 |
| FY2025 | $122,638 |
| FY2024 | $367,248 |
| FY2023 | $49,900 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $176,800 | |
| 2 | Department of Veterans Affairs | $33,000 | |
| 3 | Department of Agriculture | $15,880 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Sri International | HR001125CE063 | $58,800 |
Similar vendors
About the company
Creative Biolabs Inc., a for-profit biotechnology services company based in Shirley, New York, provides custom antibody production, cell line development, protein engineering, and specialized laboratory testing services to federal research agencies exclusively as a prime contractor on small-value purchase orders, predominantly under total small business and unrestricted set-asides. The vendor operates across multiple East Yaphank and Shirley, New York facilities and has delivered 31 prime awards (97% of recent activity) totaling $1.2 million in combined potential value over the past five years.
Creative Biolabs' customer base concentrates heavily within the Department of Health and Human Services National Institutes of Health system. The National Institute of Allergy and Infectious Diseases leads by dollar value at $325 thousand across five awards, followed closely by the National Cancer Institute at $254 thousand across eight awards; these two agencies plus the National Human Genome Research Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Eye Institute together account for 74% of combined potential value. Recent concrete work includes a $112,658 sole-source nanobody affinity maturation contract with the National Cancer Institute using phage display selection for anti-human BCMA applications (September 2025), a $210,338 mouse antibody production phases contract with NIAID (September 2024), an $88,400 antibody and protein engineering delivery with the National Human Genome Research Institute (August 2026), and an $80,850 total small business award from the Department of Agriculture's Southeast Area for single domain antibody clones targeting specified antigens (March 2024). Beyond NIH institutes, the vendor has secured purchases from the Department of Veterans Affairs, the Department of the Navy's Bureau of Medicine and Surgery, the Environmental Protection Agency's Office of Research and Development, and the Army Corps of Engineers Engineer Research and Development Center.
The award footprint spans research-and-development biotechnology (20 awards) and reference laboratory testing (15 awards) under PSC Reference Laboratory Testing and PSC Drugs and Biologicals. Activity accelerated from one award in 2022 to six in 2024, but contracted to four in 2026; only two awards with combined potential value of $49 thousand face recompete completion within the next twenty-four months. The vendor holds a single subcontract role as of the source date — enzyme conjugation production services to Sri International on a Microsystems Induced Catalysis study (September 2025) — confirming a prime-centric posture. Work performance occurs at East Yaphank and Shirley, New York with one Hamilton, Montana facility referenced in NIAID LPS analysis work.
Quick answers
Is Creative Biolabs Inc. registered in SAM.gov?
Yes. Creative Biolabs Inc.'s SAM.gov registration is active through July 3, 2027.
How much has Creative Biolabs Inc. received in federal contracts?
Federal contracts obligated $122,638 to Creative Biolabs Inc. in fiscal year 2025 and $765,466 in fiscal years 2023 through 2027.
What is Creative Biolabs Inc.'s most recent federal award?
Creative Biolabs Inc.'s most recent federal contract award is Research and development (36C24526P0656), from Veterans Integrated Service Network 5 (VHA), on September 25, 2026.
On GovTribe
See Creative Biolabs Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors